Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.
about
Origins, structures, and functions of circulating DNA in oncologyYttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal CancerColorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.Role of circulating free DNA in colorectal cancer.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastasesThe prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma.Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.Microbial markers in colorectal cancer detection and/or prognosis.A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors.Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
P2860
Q30249103-8AF64EAC-76AC-4EE3-AFF7-F95904930E53Q30353464-9F9363FB-8FAB-48E8-B966-D8D9B51F431AQ33841321-1C768A6F-519C-45A1-89D0-394AB4A8C9DBQ36277022-25642209-240B-4713-8A0E-76416732BE4FQ37539515-44DCB111-8C55-4190-B6A6-7D7300121A32Q37673704-011B4498-E911-486A-9EE2-9EFC3F4A10B3Q38375059-A94CC973-C87F-4434-B3EF-ABF1F916BE16Q38679229-6306BE49-A018-4DB5-A0F9-274B5775C109Q39051652-71713219-2922-45A1-B762-92DDE3805DCAQ39149201-BD545AC8-01EB-48A5-99E1-BF236F14A25BQ40431521-94C38F0E-E876-409F-B39E-F3A07A90251DQ41347759-FFCCF96B-74DF-4003-AA17-5331E43E4837Q42316697-6E58A40D-77E3-4676-9161-4D477C1D0E4AQ42687570-7B8F12AF-17C5-4B76-BA4C-20FB9700EB3BQ43763245-A9380279-FD85-4181-9612-6F5C76D843C9Q47563363-AD4C7F51-923E-427D-97CE-85D490401F9EQ47984460-E669BFB5-17E6-4E90-B015-9620DE312DC8Q48178985-F5065CE6-B8C6-41EB-8439-AE34E1ADDF66Q48181330-C3895290-8F34-43D1-A110-0D001057FE6AQ52660142-323F2637-D14B-4ED9-8427-B659FD9A38A9Q54113620-EE438B01-8251-4670-9350-3CAB670FB01CQ54919155-6C2CBE6C-E96C-4EED-8DA6-AC0D8C0074BCQ55094334-C1422219-0D44-4CA1-8866-BAE647A687B2Q55097882-526E24F0-D923-4874-8D3F-635011601C69Q58704645-53B395F7-0525-4FC9-9EC0-AE7DB70A5565
P2860
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Circulating DNA as a Strong Mu ...... ancer Patient Management Care.
@en
type
label
Circulating DNA as a Strong Mu ...... ancer Patient Management Care.
@en
prefLabel
Circulating DNA as a Strong Mu ...... ancer Patient Management Care.
@en
P2093
P50
P1476
Circulating DNA as a Strong Mu ...... ancer Patient Management Care.
@en
P2093
Alain R Thierry
Brigitte Gillet
Caroline Bascoul-Mollevi
Catherine Fiess
Denis Pezet
Evelyne Crapez
Frederic Bibeau
Michelle Nouaille
Safia El Messaoudi
Thibault Mazard
P304
P356
10.1158/1078-0432.CCR-15-0297
P407
P577
2016-02-04T00:00:00Z